HB1772 Relative to prescribing ibogaine for investigational use only.
Relative to prescribing ibogaine for investigational use only.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
New treatment options for opioid addiction could reduce the enormous economic costs of the ongoing opioid crisis in NH.
Your Community
NH has been hit hard by the opioid crisis; any promising addiction treatment tool deserves careful exploration.
Your Freedom
Expands treatment options for individuals struggling with addiction, supporting patient autonomy in medical decisions.
Status
Conference Committee Report 2026-2090c: Adopted, Voice Vote 06/04/2026 House Journal 15
Sponsor
Michael Moffett (R)
The Short Version
Would allow ibogaine to be prescribed for investigational use, providing a potential new treatment for opioid addiction under medical supervision. Advancing through Senate Health committee.
Who's Behind This Bill?
Who Benefits
- ▲ Individuals with opioid addiction seeking treatment
- ▲ Families affected by opioid crisis
- ▲ Addiction treatment providers
Who Pays the Price
- ▼ Patients facing risks of investigational treatment
- ▼ Regulatory systems managing new treatment protocols
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.